Sunshine Biopharma Files 8-K for Other Events
Ticker: SBFMW · Form: 8-K · Filed: Jul 1, 2024 · CIK: 1402328
| Field | Detail |
|---|---|
| Company | Sunshine Biopharma, Inc (SBFMW) |
| Form Type | 8-K |
| Filed Date | Jul 1, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-event, filing
Related Tickers: SBFM
TL;DR
Sunshine Biopharma dropped an 8-K for 'Other Events' - could be anything, watch closely.
AI Summary
Sunshine Biopharma, Inc. filed an 8-K on June 28, 2024, reporting "Other Events." The filing indicates a change in the company's status or significant corporate actions, though specific details of these events are not elaborated upon in the provided text. The company, previously known as Mountain West Business Solutions, Inc., is incorporated in Colorado and headquartered in Fort Lauderdale, Florida.
Why It Matters
This 8-K filing signals that Sunshine Biopharma has experienced significant corporate events that require public disclosure, potentially impacting its stock and investor outlook.
Risk Assessment
Risk Level: medium — The filing is an 8-K for 'Other Events' without specific details, making it difficult to assess the immediate impact or risk without further information.
Key Numbers
- 001-41282 — Commission File Number (Identifies the company's SEC filing history)
- 20-5566275 — IRS Employer ID No. (Company's tax identification number)
Key Players & Entities
- Sunshine Biopharma, Inc. (company) — Registrant
- Mountain West Business Solutions, Inc. (company) — Former company name
- June 28, 2024 (date) — Date of earliest event reported
- 333 Las Olas Way, CU4 Suite 433 Fort Lauderdale , FL 33301 (address) — Principal executive offices
FAQ
What specific 'Other Events' are being reported by Sunshine Biopharma, Inc. in this 8-K filing?
The provided text of the 8-K filing does not specify the details of the 'Other Events'.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on June 28, 2024.
What is Sunshine Biopharma, Inc.'s principal executive office address?
Sunshine Biopharma, Inc.'s principal executive office is located at 333 Las Olas Way, CU4 Suite 433, Fort Lauderdale, FL 33301.
What was Sunshine Biopharma, Inc. formerly known as?
Sunshine Biopharma, Inc. was formerly known as Mountain West Business Solutions, Inc.
In which state is Sunshine Biopharma, Inc. incorporated?
Sunshine Biopharma, Inc. is incorporated in Colorado.
Filing Stats: 419 words · 2 min read · ~1 pages · Grade level 10.6 · Accepted 2024-07-01 16:05:15
Key Financial Figures
- $0.001 — ch Registered Common Stock, par value $0.001 SBFM The Nasdaq Stock Market LLC
Filing Documents
- sunshine_8k.htm (8-K) — 26KB
- 0001683168-24-004572.txt ( ) — 236KB
- sbfm-20240628.xsd (EX-101.SCH) — 3KB
- sbfm-20240628_def.xml (EX-101.DEF) — 26KB
- sbfm-20240628_lab.xml (EX-101.LAB) — 36KB
- sbfm-20240628_pre.xml (EX-101.PRE) — 25KB
- sunshine_8k_htm.xml (XML) — 5KB
01. Other Events
Item 8.01. Other Events. On June 28, 2024, Sunshine Biopharma, Inc. (the "Company") received a notification letter from The Nasdaq Stock Market LLC ("Nasdaq"), informing the Company that the Nasdaq Hearings Panel has granted the Company's request for an exception until August 26, 2024, to regain compliance with Nasdaq's minimum bid price requirement under Listing Rule 5550(a)(2). 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: July 1, 2024 SUNSHINE BIOPHARMA, INC. By: /s/ Dr. Steve N. Slilaty Dr. Steve N. Slilaty, Chief Executive Officer 3